
Anticancer Effect of Solid-Lipid Nanoparticles Containing Mentha longifolia and Mentha pulegium Essential Oils: In Vitro Study on Human Melanoma and Breast Cancer Cell Lines
Publication year - 2021
Publication title -
biointerface research in applied chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 11
ISSN - 2069-5837
DOI - 10.33263/briac122.21282137
Subject(s) - solid lipid nanoparticle , essential oil , viability assay , chemistry , in vivo , breast cancer , cancer , pharmacology , zeta potential , traditional medicine , in vitro , medicine , biology , nanoparticle , chromatography , biochemistry , materials science , drug , nanotechnology , microbiology and biotechnology
Breast cancer and melanoma are common cancers with several treatments such as surgery, radiotherapy, chemotherapy, and their side effects. Therefore, new drugs using plant-derived substances (especially essential oils) have received more attention in recent years; however, they are generally less effective than synthetic drugs. Therefore, the preparation of essential oil-based nanoformulations is considered a promising approach to improving their efficiency. In this study, ingredients of Mentha longifolia and Mentha pulegium essential oils were first identified by GC-MS analysis. Their anticancer effects were then evaluated against one melanoma cell line (A-375) and two breast cancer cell lines (MDA-MB-468 and MCF-7). The cytotoxic effect of the essential oil on all cell lines at even the highest concentration, 1200 µg/mL, was not proper (viability > 55%). After that, solid lipid nanoparticles containing each essential oil with particle sizes of 107 ± 9 (PDI 0.274) and 191 ± 8 (PDI 0.174) nm and zeta potential -7.10 and -4.81 mV were prepared. Interestingly, both prepared nanoformulations reduced the viability of all three cell lines to around 10% at half the mentioned concentration, 600 µg/mL. Thus, the prepared nanoformulations could be introduced as proper candidates for investigation in-vivo research and supplementary medicine.